Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rocco, M. V.
Right arrow Articles by Burkart, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rocco, M. V.
Right arrow Articles by Burkart, J. M.

Journal of the American Society of Nephrology, Vol 4, 1184-1191, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

The efficacy number as a predictor of morbidity and mortality in peritoneal dialysis patients

MV Rocco, JR Jordan and JM Burkart
Department of Medicine/Nephrology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157-1053.

The efficacy number has been proposed as a predictor of clinical outcome in patients on chronic ambulatory peritoneal dialysis (CAPD). The usefulness of this parameter in a large group of CAPD patients was analyzed. Forty-five patients who have received chronic CAPD therapy for at least 1 yr were included in the study. The efficacy number was compared with outcome as defined by mortality and days of hospitalization. Other demographic and laboratory parameters, including gender; race; presence of diabetes; serum albumin, serum creatinine, and BUN levels; and measures of peritoneal transport, including dialysate-to-plasma creatinine and dialysate-to-plasma urea ratios, were also assessed for their role in predicting outcome. Laboratory values were obtained at the initiation of CAPD and at 12 months after the start of CAPD. By univariate analysis, a low 12-month serum albumin level was the best predictor of mortality (P < 0.005), followed by a high 12-month efficacy number (P < 0.05). After adjusting for age and the presence of diabetes, these two variables remained the best predictors of mortality (P < 0.08 and < 0.09, respectively). A low initial serum albumin level was also a strong predictor of mortality (P < 0.09). By univariate analysis, the best predictor of hospitalization was a low serum albumin level obtained either initially or at 12 months (P < 0.005 for both time periods). After adjusting for age and the presence of diabetes, the 12-month serum albumin level remained a significant predictor of hospitalization (P < 0.03), whereas efficacy number was not a strong predictor (P = 0.27).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
K. S. Brimble, M. Walker, P. J. Margetts, K. K. Kundhal, and C. G. Rabbat
Meta-Analysis: Peritoneal Membrane Transport, Mortality, and Technique Failure in Peritoneal Dialysis
J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2591 - 2598.
[Abstract] [Full Text] [PDF]

Home page
 Nutr Clin PractHome page
D. S. Seres
Surrogate Nutrition Markers, Malnutrition, and Adequacy of Nutrition Support
Nutr Clin Pract, June 1, 2005; 20(3): 308 - 313.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. C. Holland and M. Lam
Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study
Nephrol. Dial. Transplant., May 1, 2000; 15(5): 650 - 658.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673